Literature DB >> 33977491

Studying Metabolic Abnormalities in the Costello Syndrome HRAS G12V Mouse Model: Isolation of Mouse Embryonic Fibroblasts and Their In Vitro Adipocyte Differentiation.

Miray Fidan1, Saravanakkumar Chennappan2, Ion Cristian Cirstea3.   

Abstract

Costello syndrome (CS), characterized by a developmental delay and a failure to thrive, is also associated with an impaired lipid and energy metabolism. White adipose tissue is a central sensor of whole-body energy homeostasis, and HRAS hyperactivation may affect adipocyte differentiation and mature adipocyte homeostasis. An extremely useful tool for delineating in vitro intrinsic cellular signaling leading to metabolic alterations during adipogenesis is mouse embryonic fibroblasts, known to differentiate into adipocytes in response to adipogenesis-stimulating factors. Here, we describe in detail the isolation and maintenance of CS HRAS G12V mouse embryonic fibroblasts, their differentiation into adipocytes, and an assessment of adipocyte differentiation.

Entities:  

Keywords:  Adipocyte; Costello syndrome; Development; Embryonic; Fibroblast; Metabolism; Mouse model; RASopathy

Year:  2021        PMID: 33977491     DOI: 10.1007/978-1-0716-1190-6_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

1.  Generation and culture of mouse embryonic fibroblasts.

Authors:  Yu Lei
Journal:  Methods Mol Biol       Date:  2013

2.  Murine embryonic fibroblast cell lines differentiate into three mesenchymal lineages to different extents: new models to investigate differentiation processes.

Authors:  Khaled Dastagir; Kerstin Reimers; Andrea Lazaridis; Sabrina Jahn; Viktor Maurer; Sarah Strauß; Nadjib Dastagir; Christine Radtke; Andreas Kampmann; Vesna Bucan; Peter M Vogt
Journal:  Cell Reprogram       Date:  2014-08       Impact factor: 1.987

3.  Derivation of primary mouse embryonic fibroblast (PMEF) cultures.

Authors:  Alastair S Garfield
Journal:  Methods Mol Biol       Date:  2010

4.  Diverging gain-of-function mechanisms of two novel KRAS mutations associated with Noonan and cardio-facio-cutaneous syndromes.

Authors:  Ion C Cirstea; Lothar Gremer; Radovan Dvorsky; Si-Cai Zhang; Roland P Piekorz; Martin Zenker; Mohammad Reza Ahmadian
Journal:  Hum Mol Genet       Date:  2012-10-11       Impact factor: 6.150

Review 5.  Ras oncogenes: split personalities.

Authors:  Antoine E Karnoub; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

6.  LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity.

Authors:  Mylène Tajan; Aurélie Batut; Thomas Cadoudal; Simon Deleruyelle; Sophie Le Gonidec; Céline Saint Laurent; Maëlle Vomscheid; Estelle Wanecq; Karine Tréguer; Audrey De Rocca Serra-Nédélec; Claire Vinel; Marie-Adeline Marques; Joffrey Pozzo; Oksana Kunduzova; Jean-Pierre Salles; Maithé Tauber; Patrick Raynal; Hélène Cavé; Thomas Edouard; Philippe Valet; Armelle Yart
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

Review 7.  An unexpected new role of mutant Ras: perturbation of human embryonic development.

Authors:  Christian P Kratz; Charlotte M Niemeyer; Martin Zenker
Journal:  J Mol Med (Berl)       Date:  2007-01-09       Impact factor: 4.599

8.  Mice with an Oncogenic HRAS Mutation are Resistant to High-Fat Diet-Induced Obesity and Exhibit Impaired Hepatic Energy Homeostasis.

Authors:  Daiju Oba; Shin-Ichi Inoue; Sachiko Miyagawa-Tomita; Yasumi Nakashima; Tetsuya Niihori; Seiji Yamaguchi; Yoichi Matsubara; Yoko Aoki
Journal:  EBioMedicine       Date:  2017-12-06       Impact factor: 8.143

9.  A restricted spectrum of NRAS mutations causes Noonan syndrome.

Authors:  Ion C Cirstea; Kerstin Kutsche; Radovan Dvorsky; Lothar Gremer; Claudio Carta; Denise Horn; Amy E Roberts; Francesca Lepri; Torsten Merbitz-Zahradnik; Rainer König; Christian P Kratz; Francesca Pantaleoni; Maria L Dentici; Victoria A Joshi; Raju S Kucherlapati; Laura Mazzanti; Stefan Mundlos; Michael A Patton; Margherita Cirillo Silengo; Cesare Rossi; Giuseppe Zampino; Cristina Digilio; Liborio Stuppia; Eva Seemanova; Len A Pennacchio; Bruce D Gelb; Bruno Dallapiccola; Alfred Wittinghofer; Mohammad R Ahmadian; Marco Tartaglia; Martin Zenker
Journal:  Nat Genet       Date:  2009-12-06       Impact factor: 38.330

10.  Germline mutations in HRAS proto-oncogene cause Costello syndrome.

Authors:  Yoko Aoki; Tetsuya Niihori; Hiroshi Kawame; Kenji Kurosawa; Hirofumi Ohashi; Yukichi Tanaka; Mirella Filocamo; Kumi Kato; Yoichi Suzuki; Shigeo Kure; Yoichi Matsubara
Journal:  Nat Genet       Date:  2005-09-18       Impact factor: 38.330

View more
  1 in total

Review 1.  Multidisciplinary Management of Costello Syndrome: Current Perspectives.

Authors:  Chiara Leoni; Germana Viscogliosi; Marco Tartaglia; Yoko Aoki; Giuseppe Zampino
Journal:  J Multidiscip Healthc       Date:  2022-06-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.